Michelle Hinze
Foot & Ankle Surgery · Bellevue, NENPI 1053354944
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,172 of the $2,564 with a category attached, or 84.7%. 14 manufacturers reported payments, led by Stryker at 31.4% of the total. Reporting peaked in 2024 at $707 and has fallen 60.2% since, to $282 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NE, where the typical reported total is $5,810.
Across 70 payments — averaging $36.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$806
- Organogenesis Inc.$803
- Conetic Solutions, Inc.$485
- Musculoskeletal Transplant Foundation Inc.$121
- Penumbra, Inc.$106
- Smith+Nephew$78
- plus $165 from 8 others
What the payments were for
- Food & beverage$2,17285%
- Education$39215%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 20 | $806 |
| Organogenesis Inc. | 28 | $803 |
| Conetic Solutions, Inc. | 5 | $485 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $121 |
| Penumbra, Inc. | 1 | $106 |
| Smith+Nephew | 4 | $78 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Orthofix Medical, Inc. | 3 | $30 |
| Solventum Corporation | 1 | $27 |
| Nevro Corp. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $17 |
| Amgen | 1 | $16 |
| Medtronic | 1 | $14 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo$212
- OMEGA$173
- CITREFIX$169
- ORTHOLOC 2 LAPIFUSE$142
- PuraPly$116
How this compares
$2,564 in reported general payments places this provider in the 30th percentile of 43 foot & ankle surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Linezolid | 20 | $1,385 |
| Gabapentin | 63 | $563 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $301 |
| Doxycycline Hyclate | 16 | $203 |
| Levofloxacin | 20 | $106 |
| Methylprednisolone | 14 | $93 |
| Meloxicam | 32 | $68 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bellevue
- David WatersHastings$214K
- Eric SoLincoln$94K
- Bradley CoppleOmaha$83K
- Zackary GangwerNorfolk$66K
- Jason BaileyNorfolk$51K
- Joshua VestLincoln$40K
- Robert GreenhagenOmaha$29K
- Patrick NelsonOmaha$28K
- Michael ZimmermanOneill$26K
- Matthew WilliamsonLincoln$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.